iBio, Inc.
IBIO
$4.52
-$0.34-7.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.25% | 56.01% | 61.69% | 69.54% | 66.37% |
| Total Depreciation and Amortization | -3.29% | 1.59% | 15.00% | 29.18% | 26.51% |
| Total Amortization of Deferred Charges | -100.00% | -89.73% | -50.41% | 1.00% | 3.91% |
| Total Other Non-Cash Items | -9.20% | -65.02% | -70.23% | -87.00% | -82.45% |
| Change in Net Operating Assets | -314.90% | -141.78% | -153.98% | -112.44% | -85.00% |
| Cash from Operations | 14.80% | 22.40% | 39.04% | 49.50% | 51.62% |
| Capital Expenditure | 30.82% | 93.56% | 96.73% | 94.59% | 97.01% |
| Sale of Property, Plant, and Equipment | -97.51% | -97.51% | -95.54% | -73.81% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.18% | -77.58% | -90.77% | -93.22% | -40.40% |
| Cash from Investing | -81.09% | -77.68% | -87.07% | -86.07% | 3,671.12% |
| Total Debt Issued | -- | 79.00% | 79.00% | 79.00% | -100.00% |
| Total Debt Repaid | 56.02% | 83.66% | 78.88% | 80.66% | 38.61% |
| Issuance of Common Stock | 26.89% | 69.55% | 123.20% | 91.61% | 263.71% |
| Repurchase of Common Stock | 100.00% | 82.05% | 82.05% | 82.05% | 82.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 104.55% | 100.00% |
| Cash from Financing | 65.74% | 501.87% | 964.49% | 3,271.94% | 655.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,763.06% | 158.44% | 132.46% | 88.80% | 100.27% |
